跳至主要内容
临床试验/CTRI/2021/09/036423
CTRI/2021/09/036423尚未招募未知

A Prospective, Multicenter Study to Evaluate Real-world Effectiveness and Safety of Endoxifen as a maintenance treatment in Patients of bipolar I mood spectrum, from mania with or without depressive symptoms to depression with or without manic symptoms in clinical practice setting

Dr G Prasad Rao0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Pms

入排标准

入选标准

  • 1 Male and female patients, aged 18 years or older at time of initiation of endoxifen as a maintenance treatment based on independent clinical judgment of treating physician.2 Patients with bipolar type I disorder (bipolar I mood spectrum) from mania with or without depressive symptoms to depression with or without manic symptoms.3 Patients with the complete and relevant medical records available.4 Participants and their legally-acceptable representative must sign ICF allowing data collection and source data verification in accordance with local requirements.

排除标准

  • A patient will be withdrawn from data collection within the study for any of the following reasons:
  • -Lost to follow-up
  • -Withdrawal of consent

研究者

发起方
Dr G Prasad Rao

相似试验